Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Dora Niedersüß-Beke"'
Autor:
Klaus-Peter Dieckmann, Tomas Pokrivcak, Lajos Geczi, David Niehaus, Inken Dralle-Filiz, Cord Matthies, Tamas Dienes, Stefanie Zschäbitz, Pia Paffenholz, Tanja Gschliesser, Renate Pichler, Michal Mego, Pia Bader, Friedemann Zengerling, Julia Heinzelbecker, Philipp Krausewitz, Susanne Krege, Gaetano Aurilio, Cem Aksoy, Marcus Hentrich, Christoph Seidel, Péter Törzsök, Tim Nestler, Matthaeus Majewski, Andreas Hiester, Tomas Buchler, Sonia Vallet, Hana Studentova, Sandra Schönburg, Dora Niedersüß-Beke, Julia Ring, Emanuela Trenti, Axel Heidenreich, Christian Wülfing, Hendrik Isbarn, Uwe Pichlmeier, Martin Pichler
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Introduction: Clinical stage 1 (CS1) nonseminomatous (NS) germ cell tumors involve a 30% probability of relapse upon surveillance. Adjuvant chemotherapy with one course of bleomycin, etoposide, and cisplatin (1xBEP) can reduce this risk to pT2 was si
Externí odkaz:
https://doaj.org/article/6fb1f473ab9e4ce38bbec32affcc8d33
Autor:
Dora Niedersüß-Beke, Manuel Orlinger, David Falch, Cordula Heiler, Gudrun Piringer, Josef Thaler, Wolfgang Hilbe, Andreas Petzer, Holger Rumpold
Publikováno v:
Cancers, Vol 13, Iss 9, p 2091 (2021)
We aimed to investigate the effectiveness of oncological treatments in metastatic CRC related to comorbidities and age. This retrospective study included 1105 patients from three oncological centers. aaCCI and CCI was available from 577 patients. An
Externí odkaz:
https://doaj.org/article/5fc49537697f4a008255c9595e665960
Autor:
Karl Mayrhofer, Dora Niedersüß-Beke
Publikováno v:
memo - Magazine of European Medical Oncology. 16:52-55
Publikováno v:
memo - Magazine of European Medical Oncology. 15:165-168
Autor:
Johannes Schöche, Dora Niedersüß-Beke
Publikováno v:
memo - Magazine of European Medical Oncology. 15:39-44
Autor:
Karl Mayrhofer, Dora Niedersüß-Beke
Publikováno v:
memo - Magazine of European Medical Oncology. 15:133-136
Autor:
Dora Niedersüß-Beke, Karl Mayrhofer
Publikováno v:
memo - Magazine of European Medical Oncology. 14:335-337
Autor:
Dora Niedersüß-Beke
Publikováno v:
memo - Magazine of European Medical Oncology. 16:4-4
Autor:
Dora Niedersüß-Beke, Karl Mayrhofer
Publikováno v:
memo - Magazine of European Medical Oncology. 13:78-83
The optimal surveillance strategy in renal cell carcinoma after curative resection or ablation is a field of ongoing research. This review discusses the evidence behind routine follow up, duration of follow up, imaging modality and intervals as well
Autor:
Wolfgang Loidl, Michael Mitterberger, Hanno Gerritsmann, Bernhard Mraz, Gennadi Tulchiner, Manuela Schmidinger, Ursula M. Vogl, Clemens Georg Wiesinger, Renate Pichler, Matthias Kretz, Thomas Bauernhofer, H. Stöger, Gottfried Pfleger, Franz Kratochvill, Christoph Tinchon, Martin Marszalek, Dora Niedersüß-Beke
Publikováno v:
Clinical Genitourinary Cancer. 17:e957-e967
Background Treatment decisions in routine clinical practice are based on reports of clinical trials, which represent highly selected populations. Limited studies reported real-world evidences representing routine clinical practices in patients with r